Characteristics of patients receiving etanercept and/or adalimumab
| Prescribed Drug Register cohort | ARTIS cohort* | |
|---|---|---|
| N | 6510 | 5673 |
| Etanercept | 4617 | 3867 |
| Adalimumab | 2596 | 2059 |
| Women, N (%) | 5026 (77%) | 4382 (77%) |
| Age (years), mean (95% CI) | 55.5 (55.1 to 55.8) | 55.4 (55.1 to 55.8) |
| Education level | ||
| ≤9 years | 26% | 26% |
| 10–12 years | 45% | 45% |
| >12 years | 29% | 29% |
↵* Patients registered in the Swedish Biologics Register ARTIS with treatment with a biological agent between 2006 and 2008 and also present in the Prescribed Drug Register.